The prognostic value of IDH mutations and MGMT promoter status in secondary high-grade gliomas-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The prognostic value of IDH mutations and MGMT promoter status in secondary high-grade gliomas

Published:2012-09-27 Issue:3 Volume:110 Page:325-333
ISSN:0167-594X
Container-title:Journal of Neuro-Oncology
language:en
Short-container-title:J Neurooncol

Author:

Juratli T. A.,Kirsch M.,Geiger K.,Klink B.,Leipnitz E.,Pinzer T.,Soucek S.,Schrok E.,Schackert G.,Krex D.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Clinical Neurology,Neurology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s11060-012-0977-2.pdf

Reference22 articles.

1. Louis D OH, Wiestler O, Cavenee W (eds) (2007) World Health Organization Classification of Tumors of the Central Nervous System, IARC, Lyon

2. Ohgaki H, Kleihues P (2007) Genetic pathways to primary and secondary glioblastoma. Am J Pathol 170:1445–1453. doi: 10.2353/ajpath.2007.070011

3. Hesson LB, Krex D, Latif F (2008) Epigenetic markers in human gliomas: prospects for therapeutic intervention. Expert Rev Neurother 8:1475–1496. doi: 10.1586/14737175.8.10.1475

4. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, Olivi A, McLendon R, Rasheed BA, Keir S, Nikolskaya T, Nikolsky Y, Busam DA, Tekleab H, Diaz LA, Hartigan J, Smith DR, Strausberg RL, Marie SK, Shinjo SM, Yan H, Riggins GJ, Bigner DD, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW (2008) An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807–1812. doi: 10.1126/science.1164382

5. Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ, Friedman H, Friedman A, Reardon D, Herndon J, Kinzler KW, Velculescu VE, Vogelstein B, Bigner DD (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765–773. doi: 10.1056/NEJMoa0808710

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ex Vivo Modeling of the Tumor Microenvironment to Develop Therapeutic Strategies for Gliomas;Advanced Therapeutics;2024-06-16

2. Molecular testing for gliomas;Diagnostic Molecular Pathology;2024

3. Deep learning for image classification between primary central nervous system lymphoma and glioblastoma in corpus callosal tumors;Journal of Neurosciences in Rural Practice;2023-06-15

4. An overview of glioblastoma multiforme and temozolomide resistance: can LC-MS-based proteomics reveal the fundamental mechanism of temozolomide resistance?;Frontiers in Oncology;2023-04-26

5. Therapies for IDH-Mutant Gliomas;Current Neurology and Neuroscience Reports;2023-04-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3